Summary

The hematology diagnostics market was valued at $10.9 billion in 2022 and is estimated to reach $16.9 billion by 2032, exhibiting a CAGR of 4.4% from 2023 to 2032. The field of hematology is concerned with the physical, pathological, etiological, diagnostic, therapeutic, prognostic and preventive aspects of blood diseases and disorders. It refers to the science and practice of diagnosing and treating blood disorders, malignancies and diseases related to blood such as hemophilia, anemia, thrombocytopenia, blood clotting, leukemia, lymphoma and myeloma, as well as sickle cell anemia. Hematology diagnosis focuses mainly on the lymphatic system and bone marrow and can diagnose blood count abnormalities or platelet abnormalities.

Blood is composed of multiple components, including plasma (which makes up approximately 55% of the volume) and red, white, and platelet cells (which together make up approximately 45% of the volume). About 45% of entire blood is composed of red blood cells, usually referred to as erythrocytes or RBCs, transport oxygen from the lungs to the body's tissue. White blood cells, also produced in the bone marrow and referred to as leukocytes or WBCs, aid in the fight against infection. They comprise less than 1% of whole blood, together with platelets. Diagnosis of diseases related to these cells such as hematologic malignancies, coagulopathy, anemia, and hemoglobinopathy are considered under hematology diagnostics. Various instruments and consumables are used in the process of hematology diagnosis for blood collections and screening.
The most commonly performed hematology test is the complete blood count, or CBC. This test is frequently performed as part of a routine examination, and can identify infections, immune system diseases, blood malignancies, anemia, and clotting issues. CBC hematology test includes platelet count, hematocrit red blood cell volume (HCT), hemoglobin concentration (HB), differential white blood count, red blood cell indices and red blood cell count (RBC).

Major factors driving the growth of hematology diagnostics market include rising incidences of blood disorders, rising prevalence of chronic diseases requiring regular hematological testing, and rising awareness among population regarding routine physical checkups. The need for hematology diagnostics is growing as the incidences of blood disorders increase. It is necessary to carry out routine testing and monitoring on patients with suspected or confirmed blood disorders in order to make a diagnosis, assess the severity of the problem, and monitor its course. This is driving the market for hematology diagnostics.

In addition, effective treatment and management of blood diseases depend on early diagnosis and detection of the condition. The significance of early diagnosis has become more widely recognized because of the increased incidences of these illnesses. Hematology test recommendations and execution are mostly recommended by the healthcare professionals, which is fueling the market's expansion.
The market for hematology diagnostics is segmented on the basis of product type, test type, end user, and region. On the basis of product type, the market is segmented into hematology instrument and hematology consumables. The hematology instrument segment is further segmented into hematology analyzers, flow cytometers and others. The hematology analyzers segment is further segmented into fully automated hematology analyzers and semi-automated hematology analyzers, whereas flow cytometry segment is further segmented into cell-based flow cytometry and bead-based flow cytometry. On the basis of test type, the market is segmented into complete blood count (CBC), platelet function test, hemoglobin test and others. Based on end user, the market is segmented into Hospitals & clinics, diagnostic laboratories, and others.
By region, the market is analyzed across North America, Europe, Asia-Pacific and LAMEA. Major players profiled in this report are Cardinal Health Inc., Danaher Corporation, Siemens AG, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., F. Hoffmann-La Roche Ltd., Sysmex Corporation, Abbott Laboratories, EKF Diagnostics Holdings plc, Nihon Kohden Corporation, and Erba Group.

Key Benefits For Stakeholders
●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the hematology diagnostics market analysis from 2022 to 2032 to identify the prevailing hematology diagnostics market opportunities.
●The market research is offered along with information related to key drivers, restraints, and opportunities.
●Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
●In-depth analysis of the hematology diagnostics market segmentation assists to determine the prevailing market opportunities.
●Major countries in each region are mapped according to their revenue contribution to the global market.
●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
●The report includes the analysis of the regional as well as global hematology diagnostics market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:
● Quarterly Update and* (only available with a corporate license, on listed price)
● 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
● Free Upcoming Version on the Purchase of Five and Enterprise User License.
● 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
● 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
● Free data Pack on the Five and Enterprise User License. (Excel version of the report)
● Free Updated report if the report is 6-12 months old or older.
● 24-hour priority response*
● Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
● Regulatory Guidelines
● Additional company profiles with specific to client's interest
● Additional country or region analysis- market size and forecast
● Expanded list for Company Profiles
● Historic market data
● SWOT Analysis
Key Market Segments
By Product Type
● Hematology Instrument
○ Type
○ Hematology Analyzers
◦ Type
○ Flow Cytometry
◦ Type
○ Others
● Hematology Consumables
By Test Type
● Complete Blood Count (CBC)
● Platelet Function Testing
● Hemoglobin Testing
● Others
By End User
● Hospitals and Clinics
● Diagnostic Laboratories
● Others
By Region
● North America
○ U.S.
○ Canada
○ Mexico
● Europe
○ Germany
○ France
○ UK
○ Italy
○ Spain
○ Rest of Europe
● Asia-Pacific
○ Japan
○ China
○ India
○ Australia
○ South Korea
○ Rest of Asia-Pacific
● LAMEA
○ Brazil
○ Saudi Arabia
○ South Africa
○ Rest of LAMEA
● Key Market Players
○ Cardinal Health Inc.
○ Siemens AG
○ F. Hoffmann-La Roche Ltd.
○ Abbott Laboratories
○ EKF Diagnostics Holdings plc
○ Danaher Corporation
○ Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
○ Sysmex Corporation
○ Nihon Kohden Corporation
○ Erba Mannheim

ページTOPに戻る

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Low bargaining power of suppliers
3.3.2. Low threat of new entrants
3.3.3. Low threat of substitutes
3.3.4. Low intensity of rivalry
3.3.5. Low bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Growth in prevalence of chronic conditions
3.4.1.2. Growth in awareness of health and screening programs
3.4.1.3. Surge in adoption of point of care testing
3.4.2. Restraints
3.4.2.1. Product recalls by top players
3.4.2.2. Lack of skilled personnel in underdeveloped countries
3.4.3. Opportunities
3.4.3.1. Technological advancements in hematological diagnostics instruments
CHAPTER 4: HEMATOLOGY DIAGNOSTICS MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Hematology Instrument
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.2.4. Hematology Instrument Hematology Diagnostics Market by Type
4.2.4.1. Hematology Analyzers Hematology Diagnostics Market by Type
4.2.4.2. Flow Cytometry Hematology Diagnostics Market by Type
4.3. Hematology Consumables
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
CHAPTER 5: HEMATOLOGY DIAGNOSTICS MARKET, BY TEST TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Complete Blood Count (CBC)
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Platelet Function Testing
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Hemoglobin Testing
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Others
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
CHAPTER 6: HEMATOLOGY DIAGNOSTICS MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals and Clinics
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Diagnostic Laboratories
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: HEMATOLOGY DIAGNOSTICS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by Product Type
7.2.3. Market size and forecast, by Test Type
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by Product Type
7.2.5.1.2. Market size and forecast, by Test Type
7.2.5.1.3. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by Product Type
7.2.5.2.2. Market size and forecast, by Test Type
7.2.5.2.3. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Market size and forecast, by Product Type
7.2.5.3.2. Market size and forecast, by Test Type
7.2.5.3.3. Market size and forecast, by End User
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by Product Type
7.3.3. Market size and forecast, by Test Type
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by Product Type
7.3.5.1.2. Market size and forecast, by Test Type
7.3.5.1.3. Market size and forecast, by End User
7.3.5.2. France
7.3.5.2.1. Market size and forecast, by Product Type
7.3.5.2.2. Market size and forecast, by Test Type
7.3.5.2.3. Market size and forecast, by End User
7.3.5.3. UK
7.3.5.3.1. Market size and forecast, by Product Type
7.3.5.3.2. Market size and forecast, by Test Type
7.3.5.3.3. Market size and forecast, by End User
7.3.5.4. Italy
7.3.5.4.1. Market size and forecast, by Product Type
7.3.5.4.2. Market size and forecast, by Test Type
7.3.5.4.3. Market size and forecast, by End User
7.3.5.5. Spain
7.3.5.5.1. Market size and forecast, by Product Type
7.3.5.5.2. Market size and forecast, by Test Type
7.3.5.5.3. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Market size and forecast, by Product Type
7.3.5.6.2. Market size and forecast, by Test Type
7.3.5.6.3. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by Product Type
7.4.3. Market size and forecast, by Test Type
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Market size and forecast, by Product Type
7.4.5.1.2. Market size and forecast, by Test Type
7.4.5.1.3. Market size and forecast, by End User
7.4.5.2. China
7.4.5.2.1. Market size and forecast, by Product Type
7.4.5.2.2. Market size and forecast, by Test Type
7.4.5.2.3. Market size and forecast, by End User
7.4.5.3. India
7.4.5.3.1. Market size and forecast, by Product Type
7.4.5.3.2. Market size and forecast, by Test Type
7.4.5.3.3. Market size and forecast, by End User
7.4.5.4. Australia
7.4.5.4.1. Market size and forecast, by Product Type
7.4.5.4.2. Market size and forecast, by Test Type
7.4.5.4.3. Market size and forecast, by End User
7.4.5.5. South Korea
7.4.5.5.1. Market size and forecast, by Product Type
7.4.5.5.2. Market size and forecast, by Test Type
7.4.5.5.3. Market size and forecast, by End User
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Market size and forecast, by Product Type
7.4.5.6.2. Market size and forecast, by Test Type
7.4.5.6.3. Market size and forecast, by End User
7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by Product Type
7.5.3. Market size and forecast, by Test Type
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Market size and forecast, by Product Type
7.5.5.1.2. Market size and forecast, by Test Type
7.5.5.1.3. Market size and forecast, by End User
7.5.5.2. Saudi Arabia
7.5.5.2.1. Market size and forecast, by Product Type
7.5.5.2.2. Market size and forecast, by Test Type
7.5.5.2.3. Market size and forecast, by End User
7.5.5.3. South Africa
7.5.5.3.1. Market size and forecast, by Product Type
7.5.5.3.2. Market size and forecast, by Test Type
7.5.5.3.3. Market size and forecast, by End User
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Market size and forecast, by Product Type
7.5.5.4.2. Market size and forecast, by Test Type
7.5.5.4.3. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product mapping of top 10 player
8.4. Competitive dashboard
8.5. Competitive heatmap
8.6. Top player positioning, 2022
CHAPTER 9: COMPANY PROFILES
9.1. Cardinal Health Inc.
9.1.1. Company overview
9.1.2. Key executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.2. Danaher Corporation
9.2.1. Company overview
9.2.2. Key executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.3. Siemens AG
9.3.1. Company overview
9.3.2. Key executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.4. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
9.4.1. Company overview
9.4.2. Key executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.5. F. Hoffmann-La Roche Ltd.
9.5.1. Company overview
9.5.2. Key executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.5.7. Key strategic moves and developments
9.6. Sysmex Corporation
9.6.1. Company overview
9.6.2. Key executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.6.7. Key strategic moves and developments
9.7. Abbott Laboratories
9.7.1. Company overview
9.7.2. Key executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.7.6. Business performance
9.7.7. Key strategic moves and developments
9.8. EKF Diagnostics Holdings plc
9.8.1. Company overview
9.8.2. Key executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. Business performance
9.9. Nihon Kohden Corporation
9.9.1. Company overview
9.9.2. Key executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Business performance
9.10. Erba Mannheim
9.10.1. Company overview
9.10.2. Key executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio